Event Participants
Executives
6 A. Balasubramanian, Kamlesh Rao, Mayank Bathwal, Pankaj Gadgil, Rakesh Singh, Vishakha Mulye
Analysts
6 Abhijit Tibrewal, Avinash Singh, Ayush Dilodre, Chintan Shah, Nischint Chawathe, Raghav Garg
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Consolidated Revenue | +29% YoY | Broad-based growth across lending, insurance and AMC businesses |
| Total Closing AUM (Group) | ₹10 lakh+ crores | Crossed milestone as of June 30, 2026, incl. ~₹6.08 lakh crore EPFO mandate |
| NBFC AUM | ₹1,67,456 crores | +28% YoY, +5% QoQ; retail & SME at 72% of disbursements (up from 68%) |
| NBFC Disbursements | ₹21,201 crores | +34% YoY; P&C +41% YoY, MSME +37% YoY, unsecured +27% YoY (incl. LOC) |
| Consolidated PAT | ₹1,175 crores | +40% YoY; supported by NBFC and HFC profitability expansion |
| NBFC PAT | ₹927 crores | +35% YoY, +12% QoQ |
| NBFC NII | ₹2,377 crores | +28% YoY, +9% QoQ; NIM incl. fees stable at 6.07% |
| NBFC ROA | 2.39% | +14 bps YoY, +8 bps QoQ; driven by credit cost improvement |
| NBFC Credit Cost | 1.03% | -27 bps YoY; outcome of 18-24 months of cohort calibration in retail/unsecured |
| NBFC GS2+GS3 | 2.4% | -127 bps YoY; ~72% of book secured; provision cover 48.2% (+40 bps QoQ) |
| NBFC GS3 (P&C / MSME / Unsecured) | 1.2% / 1.1% / 1.1% | P&C GS2+GS3 -430 bps YoY; MSME GS3 -50 bps YoY; unsecured GS3 excl. govt. guarantee ~0.47% |
| HFC AUM | ₹51,833 crores | +50% YoY, +9% QoQ; crossed ₹50,000 crore milestone; HFC PBT ₹300 crores (+95% YoY) |
| HFC ROA / ROE | 2.12% / 11.2% | ROE to scale to ~13% by Q4 FY27 exit, 15% over 6-8 quarters |
| HFC GS3 / GS2+GS3 | 0.41% / 0.78% | Best-in-class asset quality; benefitting from analytics and early warning systems |
| MF Quarterly Average AUM | ₹4.28 lakh crores | +6% YoY; equity QAUM ~₹1.9 lakh crores (+10% YoY); equity mix 46.5%; SIP ₹1,083 crores |
| AMC Revenue / PAT | ₹625 / ₹309 crores | vs ₹563 / ₹277 crores YoY; ~75% of equity AUM in top-2 quartiles |
| Life Total Premium | ₹4,743 crores | +13% YoY; individual FIP +20% YoY; 13-month persistency 83% |
| Life VNB Margin | 15.1% | Up from 7.5% YoY (+756 bps); driven by non-par, protection and annuity mix; solvency 201% |
| Health GWP (sales basis) | ₹2,196 crores | +50% YoY; market share 16.2% (+200 bps YoY); Q1 PAT ₹18 crores vs loss of ₹28 crores YoY |
| Health Combined Ratio (IFRS) | 106% | vs 107% YoY; management targeting 100% on IFRS basis in FY27 |
Geographic & Segment Commentary
NBFC Lending (Overall & Retail/MSME Mix): AUM of ₹1,67,456 crores (+28% YoY) with retail and SME accounting for 72% of disbursements (+39% YoY). Personal & Consumer book at ₹23,267 crores (+41% YoY, +9% QoQ, mix at 14%), MSME book at ₹95,099 crores (+31% YoY, 57% of AUM, 80% secured vs 20% unsecured), and corporate segment at 29% of portfolio (+16% YoY). GS2+GS3 improved 127 bps YoY to 2.4% with secured book at 72%; fee income growth of 50% YoY driven by processing fees and insurance attachments. Strategy remains focused on granular, risk-segmented growth across retail and MSME verticals.
Housing Finance (ABHFL): AUM crossed ₹50,000 crores to ₹51,833 crores (+50% YoY, +9% QoQ), disbursements grew 39% YoY to ₹7,515 crores, PBT +95% YoY to ₹300 crores. New 2026 branches launched across metros, Tier 1 and Tier 2 markets delivering parity productivity with mature branches; partner base crossed 40,000. Group ecosystem channel contributed 16.2% of retail disbursements. Target of ₹1 lakh crore+ AUM with 15% ROE over 6-8 quarters.
Asset Management (AMC): Quarterly average AUM incl. alternatives crossed ₹6 lakh crores at ₹6.28 lakh crores (+14% YoY); closing AUM crossed ₹10 lakh crores following EPFO mandate of ~₹6.08 lakh crores. Retail GIFT City license granted with FlexiCap fund fundraising underway; passive AUM grew 14% YoY. Fund performance strong with ~75% of equity AUM in top-two quartiles; equity mix at 46.5% with 40 lakh SIP accounts and ₹1,083 crore monthly SIP flows.
Life Insurance (ABSLI): Individual premium growth of 20% YoY vs industry 15%; traditional (incl. protection) at 71% of product mix, ULIP down to 29%; annuity at 16% of individual business. Partnership business grew 25% across 11 banks; proprietary business +7% YoY with improving productivity; group life segment +74% YoY. Credit Life +51% with 33% from captive NBFC/HFC sources; group AUM at ₹30,000 crores (26% of total) with 20%+ ROE. Distribution network of 450+ branches, adding 10% through the year.
Health Insurance (ABHI): Gross premium (sales basis) of ₹2,196 crores (+50% YoY), maintaining position as fastest-growing SAHI with market share up 200 bps YoY to 16.2%. Retail franchise +47% YoY (agency base ~2 lakh agents, +56% YoY), corporate business +55% YoY. Launched Activ Yuva digital-first product targeting young India. Q1 profit of ₹18 crores under IFRS vs loss of ₹28 crores YoY; combined ratio improved to 106%.
Company-Specific & Strategic Commentary
Capital Raise & Group Funding: Raised ₹4,000 crores via preferential allotment — ₹3,080 crores from promoter/promoter group, ₹920 crores from IFC (member of World Bank). 87.5% of proceeds earmarked for NBFC growth objectives, balance 12.5% for general corporate purposes incl. subsidiary investments. No further capital raise envisaged at ABCL, HFC or insurance entities over the next three years; HFC completed separate ₹2,750 crores primary infusion from Advent International.
Gold Loan Foray: Entering gold loan business with go-live in Q2 FY27; branch infrastructure and execution teams in place. Plan to scale to 200-300 standalone gold loan branches by March 2027 and ~1,000 branches over three years; pan-India coverage. Base case is organic; management open to evaluating small acquisitions if value-accretive.
AI & Digital Transformation: AI positioned as core operating layer across businesses. NBFC: 63% of contact center interactions and 71% of service e-mails processed via STP; multilingual gen-AI calling bots and conversational analytics at 100% automation. HFC: 13 AI use cases live incl. FinTellect (AI-generated credit assessment memos) and AI-enabled discrepancy checks. Life: Saras AI program for policy issuance, underwriting and servicing. Health: 74% of cashless claims processed via AI/ML engine.
Distribution & Channel Expansion: HFC launched 50 new branches in FY27 with productivity at mature-branch levels, plus Partner One next-gen partner platform. Life adding 10% to branch network; NPS improved to 67% vs 62% YoY. Health added ~2 lakh agents across proprietary and alliance channels.
Regulatory & Reporting Transition: Health Insurance implemented IFRS financial statements from Q1 FY27; first profit reported under IFRS framework. AMC received GIFT City retail license enabling NRI/global investor access to inbound India and outbound global products.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| HFC AUM | ₹1 lakh crore+ within 6-8 quarters | Current capital sufficient for target; no further raise needed before reaching ₹1 lakh crore |
| HFC ROE | ~13% by Q4 FY27 exit; 15% over 6-8 quarters | ROA range-bound at ~2.1-2.2%; growth and operating leverage to drive ROE expansion |
| HFC Opex-to-Loan Book | 2.15-2.19% for FY27 | Range-bound despite branch expansion; AI and digital productivity offsetting costs |
| Life Individual FIP | 20%+ CAGR over next 3 years | With VNB margin expansion above 20% and doubling net VNB in 3 years |
| Life Product Mix | Traditional incl. protection at 71% | ULIP controlled at 29%; annuity at 16% of individual business; variable annuity product launched Mar-26 |
| Health Combined Ratio | 100% on IFRS basis in FY27 | From 106% in Q1; claim ratios improving, health-first model unit economics scaling |
| NBFC Yield Trajectory | Yield expansion as P&C mix scales | P&C mix at 14% of AUM (vs 19% historical); target 18-19% over coming quarters; yield on P&C portfolio 16.2% |
| Gold Loan Branches | 200-300 by Mar-27; ~1,000 in 3 years | Costs budgeted in AOP; pan-India brokerage model; go-live in Q2 FY27 |
Risks & Constraints
| Risk | Context |
|---|---|
| Macro Uncertainty (Input & Energy Costs) | Management flagged higher input and energy costs making growth outlook uncertain despite strong domestic demand; near-term volatility acknowledged in operating guidance |
| Credit Life Regulatory Risk | Analyst raised concern over potential regulator curtailment of payouts/attachment on credit life products, which materially drives NBFC fee income (+50% YoY, process fees + insurance attachments); management acknowledged industry-level impact if materialized, with mitigation via group ecosystem capture |
| Yield Compression & Competitive Pressure | NBFC yields declined ~13 bps YoY despite P&C mix expansion; management expects yield expansion only as P&C scales from 14% to 18-19% over multiple quarters; competitive intensity in MSME and personal loan segments remains elevated |
| Seasonal Weakness (Q1) | Historically, Q1 sees seasonal asset quality weakness; management noted current cohorts performing better than expected with GS2/GS3 stable — but cyclicality risk remains |
| HFC ROE Dilution | ₹2,750 crores Advent infusion and branch expansion keep ROE at 11.2% vs 15% target; management guided 13% by Q4 FY27 exit and 15% only after 6-8 quarters of asset growth |
Q&A Highlights
NBFC Margins & Yield Trajectory
- Question: Is there a drop in loan spreads (yield minus cost of funds), even after adjusting for balance sheet liquidity? (Raghav Garg, AMBIT)
- Answer: Yields were stable QoQ; fee income lower by 6 bps and cost of funds benefit of 5 bps; NIM incl. fees stable at 6.07% (Kamlesh Rao)
- Question: Why have yields declined ~13 bps while P&C mix expanded from 12.5% to 14%? What is the P&C portfolio yield? (Chintan Shah, ICICI Securities)
- Answer: P&C yield at 16.2%; will take a few quarters for mix change from 24-25% unsecured to 27-30% to show yield expansion; risk-adjusted returns prioritized — no loosening of underwriting filters (Rakesh Singh)
- Question: What was the historical rate on P&C versus current? (Abhijit Tibrewal, Motilal Oswal)
- Answer: Four quarters back yield was 16.5%, now 16.2%; only ~1 percentage point difference visible now — but P&C mix was 19% historically vs 14% today; at 18-19% mix, margin expansion will be visible (Rakesh Singh)
Housing Finance Opex & ROE Path
- Question: Despite branch expansion, opex ratio is stable; will full expenses hit P&L in Q2? (Raghav Garg, AMBIT)
- Answer: Branches opened throughout the quarter (first batch April 10); opex-to-loan book at 2.21% (-10 bps); FY27 range-bound at 2.15-2.19% as manpower ramps; AI and digital productivity offsetting costs (Pankaj Gadgil)
- Question: Post capital raise, how many quarters for ROE to scale back to 15%? (Chintan Shah, ICICI Securities)
- Answer: ROE will rise ~150 bps in next 2-3 quarters to ~13% by Q4 FY27 exit; 15% in 6-8 quarters as AUM approaches ₹1 lakh crore; current capital sufficient for that target (Pankaj Gadgil)
Capital Raise & Allocation
- Question: How will the ₹4,000 crore capital be utilized and are there further raises planned? (Nischint Chawathe, Kotak)
- Answer: ₹3,080 crores from promoters, ₹920 crores from IFC; 87.5% to NBFC growth, 12.5% to insurance and other subsidiaries; no capital raise expected at ABCL, HFC or insurance for next 3 years — all entities funded for growth horizon (Rakesh Singh)
Gold Loan Foray
- Question: Which geographies will gold loan branches target? (Ayush Dilodre, Nomura)
- Answer: Pan-India presence; branches opening as locations and state readiness are completed (Rakesh Singh)
- Question: Will gold loan scale be organic or via acquisition? (Abhijit Tibrewal, Motilal Oswal)
- Answer: Organic plan is the base; will evaluate small acquisitions if opportunity for scale-up and learning arises (Pankaj Gadgil)
Credit Life Regulatory Risk & Product Expansion
- Question: Any new retail product areas beyond personal loans? Any risk to fee yield from credit life regulatory curtailment? (Avinash Singh, Emkay)
- Answer: Gold loan is the near-term expansion into secured retail; within credit life, much is within group ecosystem — mitigation possible if regulation changes; impact would be industry-level (Rakesh Singh)
Life Insurance Margin Expansion & Distribution Mix
- Question: What drove the large margin expansion and why is proprietary business down? (Nischint Chawathe, Kotak)
- Answer: Riders contributed 1.5-2% margin uptick; ULIP controlled; growing annuity (variable annuity product launched Mar-26) and non-par business; nearly half of growth came from productivity (no cost attached); direct business strong in proprietary; Banca growth at 25% is value-accretive due to small/regional bank mix (Kamlesh Rao)
Risk Management & Cohort Calibration
- Question: Any segments worth flagging as risk markers despite better-than-expected GS2/GS3? (Abhijit Tibrewal, Motilal Oswal)
- Answer: Monthly cohort and through-the-door review at segment level; out-of-appetite segments eliminated proactively over last 18-24 months before flowing into portfolio (Pankaj Gadgil)
Health Insurance Returns Economics
- Question: Does Health Returns incentive program (6-7% lower loss ratio, 11% better persistency) fully offset premium rewards? (Ayush Dilodre, Nomura)
- Answer: Health Return cohort is value-accretive at a core level — lower loss ratios and better profitability more than offset incentives (Kamlesh Rao)
Key Takeaway
Aditya Birla Capital delivered a strong Q1 FY27 with consolidated PAT up 40% YoY to ₹1,175 crores, driven by NBFC AUM growth of 28% to ₹1,67,456 crores (ROA up 14 bps to 2.39%), HFC growth of 50% to ₹51,833 crores with PBT nearly doubling, and life VNB margin expanding 756 bps YoY to 15.1%. The company raised ₹4,000 crores (87.5% earmarked for NBFC growth; HFC raised ₹2,750 crores from Advent) and guided to no further capital raises for three years. Strategy centers on retail & MSME granular growth (72% of disbursements), AI-led operating efficiency (63% contact center STP, FinTellect and Saras AI programs), and new engines including gold loans (200-300 branches by Mar-27), GIFT City products and Activ Yuva health insurance. Guidance targets HFC ₹1 lakh crore+ AUM and 15% ROE in 6-8 quarters, life 20%+ individual FIP CAGR with VNB margins above 20%, and health 100% combined ratio on IFRS basis by FY27. Watch items include yield normalization as P&C mix scales from 14% toward 19%, credit life regulatory risk, and macro cost inflation uncertainty.